Barx CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. Barx Gen Silencer sind erhältlich als Barx CRISPR/Cas9 Knockout Plasmide und Barx Double Nickase Plasmide. Barx CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
Barx CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Barx1 CRISPR/Cas9 KO Plasmid (h) | sc-406951 | h | Gene Knockout | GFP | 0 | ||
Barx1 HDR Plasmid (h) | sc-406951-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Barx1 Double Nickase Plasmid (h) | sc-406951-NIC | h | Gene Knockout | Puromycin | 0 | ||
Barx1 Double Nickase Plasmid (h2) | sc-406951-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Barx1 CRISPR/Cas9 KO Plasmid (m) | sc-419290 | m | Gene Knockout | GFP | 0 | ||
Barx1 HDR Plasmid (m) | sc-419290-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Barx1 Double Nickase Plasmid (m) | sc-419290-NIC | m | Gene Knockout | Puromycin | 0 | ||
Barx1 Double Nickase Plasmid (m2) | sc-419290-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Barx2 CRISPR/Cas9 KO Plasmid (h) | sc-403458 | h | Gene Knockout | GFP | 0 | ||
Barx2 HDR Plasmid (h) | sc-403458-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Barx2 Double Nickase Plasmid (h) | sc-403458-NIC | h | Gene Knockout | Puromycin | 0 | ||
Barx2 Double Nickase Plasmid (h2) | sc-403458-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Barx2 CRISPR/Cas9 KO Plasmid (m) | sc-419291 | m | Gene Knockout | GFP | 0 | ||
Barx2 HDR Plasmid (m) | sc-419291-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Barx2 Double Nickase Plasmid (m) | sc-419291-NIC | m | Gene Knockout | Puromycin | 0 | ||
Barx2 Double Nickase Plasmid (m2) | sc-419291-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Barx CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Barx1 CRISPR Activation Plasmid (h) | sc-406951-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activation Plasmid (h2) | sc-406951-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (h) | sc-406951-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (h2) | sc-406951-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activation Plasmid (m) | sc-419290-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activation Plasmid (m2) | sc-419290-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (m) | sc-419290-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (m2) | sc-419290-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activation Plasmid (h) | sc-403458-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activation Plasmid (h2) | sc-403458-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (h) | sc-403458-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (h2) | sc-403458-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activation Plasmid (m) | sc-419291-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activation Plasmid (m2) | sc-419291-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (m) | sc-419291-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (m2) | sc-419291-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |